• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yusa Kosuke  遊佐 宏介

ORCIDConnect your ORCID iD *help
… Alternative Names

YUSA Kosuke  遊佐 宏介

Less
Researcher Number 00813180
Affiliation (Current) 2025: 京都大学, 医生物学研究所, 教授
Affiliation (based on the past Project Information) *help 2021 – 2025: 京都大学, 医生物学研究所, 教授
2020: 京都大学, ウイルス・再生医科学研究所, 教授
Review Section/Research Field
Principal Investigator
Medium-sized Section 50:Oncology and related fields / Medium-sized Section 90:Biomedical engineering and related fields / Biological Sciences
Except Principal Investigator
Basic Section 27040:Biofunction and bioprocess engineering-related / Basic Section 54010:Hematology and medical oncology-related
Keywords
Principal Investigator
CRISPR / 合成致死 / 造血器腫瘍 / SWI/SNF / Cre / 分子標的 / 増殖必須因子 / 多発性骨髄腫 / in vivo CRISPRスクリーニング / in vivo model … More / Leukemia / Genetic screening / MM / T-ALL / スクリーニング / Flp / ゲノム編集 / in vivoモデル / 白血病 / 遺伝学的スクリーニング / CRISPR-Cas9 / 内胚葉 / 分化指向性 / 細胞分化 / 未分化能 / 多能性 / CRISPRスクリーニング / 胚性内胚葉 / 分化 / ヒトiPS細胞 / ヒトES細胞 … More
Except Principal Investigator
細胞内バイオ医薬 / キメラタンパク質 / CRISPR screen / awakening regulator / 休眠がん細胞 / fibrocyte / 骨髄線維症 Less
  • Research Projects

    (5 results)
  • Research Products

    (27 results)
  • Co-Researchers

    (6 People)
  •  SWI/SNF合成致死遺伝子による造血器腫瘍新規治療戦略の確立Principal Investigator

    • Principal Investigator
      遊佐 宏介
    • Project Period (FY)
      2025 – 2028
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Review Section
      Medium-sized Section 50:Oncology and related fields
    • Research Institution
      Kyoto University
  •  Generation and functional analysis of an awakening regulator for awakening quiescent cancer cells

    • Principal Investigator
      門之園 哲哉
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 27040:Biofunction and bioprocess engineering-related
    • Research Institution
      Institute of Science Tokyo
  •  腫瘍性fibrocyteの本態解明と、骨髄線維症診断・治療への展開

    • Principal Investigator
      下田 和哉
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 54010:Hematology and medical oncology-related
    • Research Institution
      University of Miyazaki
  •  in vivo CRISPRスクリーニングの技術確立と生体内細胞増殖機構の解析Principal Investigator

    • Principal Investigator
      遊佐 宏介
    • Project Period (FY)
      2021 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Review Section
      Medium-sized Section 90:Biomedical engineering and related fields
    • Research Institution
      Kyoto University
  •  Analysis of human iPSC differentiation into definitive endoderm using CRISPR screeningPrincipal Investigator

    • Principal Investigator
      YUSA Kosuke
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Fund for the Promotion of Joint International Research (Home-Returning Researcher Development Research)
    • Review Section
      Biological Sciences
    • Research Institution
      Kyoto University

All 2024 2023 2022 2021 2019 2018

All Journal Article Presentation

  • [Journal Article] Canonical BAF complex regulates the oncogenic program in human T-cell acute lymphoblastic leukemia2024

    • Author(s)
      Aoki Kazunari、Hyuga Mizuki、Tarumoto Yusuke、Nishibuchi Gohei、Ueda Atsushi、Ochi Yotaro、Sugino Seiichi、Mikami Takashi、Kobushi Hirokazu、Kato Itaru、Akahane Koshi、Inukai Takeshi、Takaori-Kondo Akifumi、Takita Junko、Ogawa Seishi、Yusa Kosuke
    • Journal Title

      Blood

      Volume: 143 Issue: 7 Pages: 604-618

    • DOI

      10.1182/blood.2023020857

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K18264, KAKENHI-PROJECT-21K08393, KAKENHI-PROJECT-22K16320, KAKENHI-PROJECT-21H04959, KAKENHI-PROJECT-23K24298
  • [Journal Article] AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors2022

    • Author(s)
      Dunn S, Eberlein C, Yu J, Gris-Oliver A, Ong SH, Yelland U, Cureton N, Staniszewska A, McEwen R, Fox M, Pilling J, Hopcroft P, Coker EA, Jaaks P, Garnett MJ, Isherwood B, Serra V, Davies BR, Barry ST, Lynch JT, Yusa K
    • Journal Title

      Oncogene

      Volume: 41 Issue: 46 Pages: 5046-5060

    • DOI

      10.1038/s41388-022-02482-9

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Journal Article] KAT7 is a genetic vulnerability of acute myeloid leukemias driven by MLL rearrangements2021

    • Author(s)
      Au YZ, Gu M, De Braekeleer E, Gozdecka M, Aspris D, Tarumoto Y, Cooper J, Yu J, Ong SH, Chen X, Tzelepis K, Huntly BJP, Vassiliou G, Yusa K.
    • Journal Title

      Leukemia

      Volume: 35 Issue: 4 Pages: 1012-1022

    • DOI

      10.1038/s41375-020-1001-z

    • NAID

      120006976051

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146, KAKENHI-PROJECT-21H04959
  • [Journal Article] Minimal genome-wide human CRISPR-Cas9 library.2021

    • Author(s)
      Goncalves E, Thomas M, Behan FM, Picco G, Pacini C, Allen F, Vinceti A, Sharma M, Jackson DA, Price S, Beaver CM, Dovey O, Parry-Smith D, Iorio F, Parts L, Yusa K, Garnett MJ.
    • Journal Title

      Genome Biology

      Volume: 22 Issue: 1

    • DOI

      10.1186/s13059-021-02268-4

    • Description
      印刷中
    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] Development and Applications of CRISPR-KO screening2023

    • Author(s)
      遊佐宏介
    • Organizer
      日本生化学会大会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development and Applications of CRISPR-KO screening2023

    • Author(s)
      遊佐宏介
    • Organizer
      日本がん学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Canonical BAF complex is essential for the RUNX1-driven oncogenic transcriptional program in human T-cell acute lymphoblastic leukemia2023

    • Author(s)
      Aoki K, Hyuga M, Tarumoto Y, Nishibuchi G, Ochi Y, Sugino S, Mikami T, Kobushi H, Kato I, Akahane K, Inukai T, Takaori-Kondo A, Takita J, Ogawa S, Yusa K.
    • Organizer
      日本血液学会国際シンポジウム
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Canonical BAF complex is essential for the RUNX1-driven oncogenic transcriptional program in human T-cell acute lymphoblastic leukemia.2023

    • Author(s)
      Aoki K, Hyuga M, Tarumoto Y, Nishibuchi G, Ochi Y, Sugino S, Mikami T, Kobushi H, Kato I, Akahane K, Inukai T, Takaori-Kondo A, Takita J, Ogawa S, Yusa K.
    • Organizer
      日本がん学会学術総会
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] CRISPR-KO スクリーニングの開発と応用2022

    • Author(s)
      遊佐宏介
    • Organizer
      第45回日本分子生物学会年会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development of CRISPR-KO Screening and its Applications in Cancer Research2022

    • Author(s)
      遊佐宏介
    • Organizer
      IAAO2022
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development and Applications of CRISPR-KO Screening2022

    • Author(s)
      遊佐宏介
    • Organizer
      第31会日本がん転移学会学術集会・総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] CRISPR-KOスクリーニングの開発とがん研究への応用2021

    • Author(s)
      遊佐宏介
    • Organizer
      日本癌学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] Genetic Dissection of Pluripotency Maintenance using CRISPR-KO Screening2021

    • Author(s)
      遊佐宏介
    • Organizer
      第110回日本病理学会総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] CRISPR-KOスクリーニングの開発と応用2021

    • Author(s)
      遊佐宏介
    • Organizer
      日本分子生物学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] CRISPR-KOスクリーニングの開発と創薬研究への応用2021

    • Author(s)
      遊佐宏介
    • Organizer
      千里ライフサイエンスシンポジウム
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] Development and Application of CRISPR-KO Screening2021

    • Author(s)
      遊佐宏介
    • Organizer
      第80会日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development and Application of CRISPR-KO Screening2021

    • Author(s)
      遊佐宏介
    • Organizer
      第73回日本細胞生物学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development and Application of CRISPR-KO Screening2021

    • Author(s)
      遊佐宏介
    • Organizer
      The 27th East Asia Joint Symposium
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] Development and Application of CRISPR-KO Screening2021

    • Author(s)
      遊佐宏介
    • Organizer
      第21回日本再生医療学会総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21H04959
  • [Presentation] CRISPR-KO スクリーニング法の開発と応用2019

    • Author(s)
      遊佐 宏介
    • Organizer
      SULSA, Scottish Universities Life Science Alliance
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] CRISPR-KOスクリーニング法の開発と応用2019

    • Author(s)
      遊佐 宏介
    • Organizer
      日本ゲノム編集学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] CRISPR-KO スクリーニング法の開発と応用2019

    • Author(s)
      遊佐 宏介
    • Organizer
      Frontiers in Genome Engineering 2019
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] CRISPR-KOスクリーニング法の開発と応用2019

    • Author(s)
      遊佐 宏介
    • Organizer
      日本遺伝学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] 大規模全ゲノムCRISPRスクリーニングによる創薬候補の探索2018

    • Author(s)
      遊佐宏介
    • Organizer
      日本分子生物学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] Identification of novel drug targets using CRISPR screens in cancer2018

    • Author(s)
      遊佐宏介
    • Organizer
      National Institute of Genetics
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] CRISPR-based genetic screening2018

    • Author(s)
      遊佐宏介
    • Organizer
      Croucher Summer Course Precision Genome Engineering by CRISPR
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K20146
  • [Presentation] Oncology drug candidates identified from genome-wide CRISPR screens of 204 cancer cell lines2018

    • Author(s)
      遊佐宏介
    • Organizer
      日本癌学会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K20146
  • 1.  青木 一成 (30618020)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 2.  下田 和哉 (90311844)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 3.  幣 光太郎 (20468028)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 4.  門之園 哲哉 (10510282)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 5.  内田 智士 (20710726)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 6.  滝田 順子
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi